|
Join Ethics & Compliance Professionals from over 100 Pharma & Device Companies @ the 23rd Pharmaceutical & Medical Device Ethics and Compliance Congress
|
- A Hybrid Onsite Conference and Internet Event
- Sponsored by Pharmaceutical Compliance Forum
- Media Partners: Policy & Medicine Compliance Update
- October 24-26, 2022
- Capitol Hyatt, Washington, DC
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com |
|
REGISTER BY 9/23 FOR EARLY BIRD RATE
|
|
Click Here for discounted registration.
|
|
|
|
CONGRESS ATTENDEES BY ORGANIZATION TYPE
|
|
|
|
PHARMA & DEVICE ATTENDEES BY POSITION
|
|
|
|
PHARMA & DEVICE COMPANIES ATTENDING
|
AbbVie
Aldevron
Allergan
Amarin Pharma
Amgen
Amryt Pharma
Argenx
Arthrex
Astellas Pharma
Astra Zeneca
Avanir Pharmaceuticals
Azurity Pharma
Bausch & Lomb
Bayer
Biogen
Boehringer Ingelheim
Bristol-Myers Squibb Company
Celgene - Merged with BMS
Chiesi
Clovis Oncology
Convatec
Corium
CSL Behring
Cytokinetics
Dermavant Sciences
Eli Lilly & Company
EMD Serono
Emergent Biosolutions
Endo Pharmaceuticals, Inc.
Epizyme
EQRx
Esperion Therapeutics
Evommune
Exelixis
Flagship Pioneering
Foundation Medicine
|
Galderma
Gedeon Richter Plc.
Genentech
Genmab
Gilead
GlaxoSmithKline
Glenmark Pharmaceuticals Inc., USA
Grifols
Harmony Biosciences
Hillrom Baxter
Horizon Therapeutics
HutchMed International
Immunocore, LLC
Incyte
Indivior
Insmed
Ipsen
Jazz Pharmaceuticals
Johnson & Johnson
kaleo, Inc.
Lumos
Mallinckrodt Pharmaceuticals
Medicines360
Medline Industries, Inc.
Medtronic
Merck
Merz Aesthetics
MiMedx
Moderna
Morphosys Ag
Mycovia Pharmaceuticals
Mylan
Neurocrine Biosciences, Inc.
Novartis
Novavax
Novo Nordisk
|
Novocure
Olympus Corporation Of The Americas
Otsuka Pharmaceutical
Pfizer
PharmaEssentia USA Corporation
Phathom Pharmaceuticals
Puma Biotechnology
Purdue
Regeneron Pharmaceuticals
Reprise Biomedical
Roche
Sage
Samsung Bioepis
Sanara Medtech
Sanofi
Seagen, Inc
Sentynl Therapeutics, Inc.
Shionogi Inc
Shire
SK Life Science, Inc.
Smith+Nephew
Spark Therapeutics
SpringWorks Therapeutics
Stryker
Sunovion Pharmaceuticals
Surgalign Spine Technologies
Syneos Health
Takeda Pharmaceuticals
Teva Pharmaceuticals
UCB, Inc.
United Therapeutics
UroGen Pharma Inc.
Us WorldMeds
Viatris Inc.
Zai Lab
|
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- SEPTEMBER 15, 2022: The Pharmaceutical Compliance Forum (PCF) executive committee is pleased to announce that the Twenty-Third Pharmaceutical & Medical Device Ethics and Compliance Congress is returning to the Hyatt Regency on Capitol Hill in Washington, DC on October 24-26, 2022.
|
|
KEYNOTE SPEAKERS
|
Charlene Keller Fullmer, JD
Assistant United States Attorney; Deputy Chief, Affirmative Litigation; US Attorney's Office for the Eastern District of Pennsylvania, Philadelphia, PA |
Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD |
Mary A. Inman, JD
Whistleblower Counsel; Partner, Constantine, San Francisco, CA and London, UK
|
Kelly Begg Lawrence, JD
Assistant US Attorney & Chief, Health Care Fraud, District of Massachusetts, US Department of Justice, Boston, MA
|
Glenn Leon, JD
Incoming Fraud Section Chief, Criminal Division, US Department of Justice; Former SVP & Chief Ethics & Compliance Officer, Hewlett Packard, Washington, DC |
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC
|
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC |
Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC
|
|
|
AND FEATURING
|
- We are thrilled to welcome you back to Washington DC for the in-person/hybrid PCF Congress!
- Join us live to take advantage of numerous interpersonal networking opportunities with colleagues and educational opportunities at our robust exhibit hall with our industry partners
- An invitation-only, closed-door Chief Compliance Officer (CCO) Roundtable on the morning of Tuesday, October 25
For more information contact pcf.org.info@gmail.com.
- Annual reports and updates provided by DOJ, FDA, and OIG
- Over 30 current topics addressing crucial ethics, compliance and legal issues
- An industry-only, closed-door session for pharma and device ethics, compliance and legal professionals on Wednesday, October 26
|
|
FEATURED FACULTY
|
Khelin N. Aiken, JD
Partner, North America FDA Practice, Baker McKenzie; Former Regulatory Counsel, FDA |
Punkaj T. Amin, MBA, CFE
Compliance Officer, Global Wound Management, Smith & Nephew |
Meredith S. Auten, JD
Partner, Morgan, Lewis & Bockius LLP
|
Kristiana Bankova, MS
Senior Manager Forensics, EY |
Eric M. Baim, MA, JD
Partner, Dovetail Consulting Group LLC; Former VP Compliance US, Shire |
Rachel Batykefer
Senior Director, Integrity & Compliance CIA Operations, Mallinckrodt
|
Ann E. Beasley, JD
Chief Compliance Officer, Zai Lab |
Allison Benkert, MBA
Director Global Compliance Investigations, Seagen |
Joshua Blank, JD
Senior Attorney, Arnold & Porter
|
Eric Bolesh
Chief Operating Officer, Cutting Edge Information |
Keysha Bradford
Director of Compliance, Amplity Health |
Jennifer Bragg, JD
Partner, Skadden Arps LLP
|
Adam L. Braverman, JD
Partner, Morrison & Foerster, Former US Attorney, Southern District of California |
Eve M. Brunts, LLM, JD
Partner, Ropes & Gray |
Terra Buckley, JD
Vice President, Head of Compliance Advisory Services, MedPro Systems; Vice President Compliance, Mesoblast
|
Tim Canonico
Principal, Pharmaceutical & Life Sciences, Risk & Regulatory Leader, PwC |
Susy Cardoso, JD, LLM
Former Executive Director of Ethics & Compliance, Amarin |
Craig Carpenito, JD
Partner, King & Spalding; Former US Attorney, New Jersey
|
Cynthia Cetani, LPEC
Chief Integrity & Compliance Officer, Indivior |
Cheryl Chamallas
Sr. Director, Global Compliance Risk, argenx |
Masha Chestukhin, MSJ
Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme
|
Shoshanna Clark, JD
Head of USBU Ethics & Compliance Operations, Takeda |
Steven Cohen, MBA
Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly |
Chris Corallo
Compliance Officer, North America, Convatec
|
Zachary Coseglia, JD
Managing Principal & Head of Innovation, R&G Insights Lab, Ropes & Gray |
Clarissa Crain
Managing Director, Deloitte & Touche LLP |
David W. Cromley, JD
Associate Vice President, Global Compliance Organization, Merck
|
Tiffany Cummings-Damiani, MBA
Head of Global Compliance, JD, Insmed Incorporated |
Donna Daniels, JD
Managing Director, Forensic & Integrity Services, EY |
Mahnu V. Davar, MA, JD
Partner, Arnold & Porter
|
BJ D’Avella, MBA
Life Sciences Consulting Group Leader, Paul Hastings |
Jake DeBoever, JD
Vice President, Chief Compliance Officer, Dermavant Sciences |
Stefanie A. Doebler, JD
Partner and Co-chair, Health Care Practice Group, Covington & Burling LLP
|
Gildas Durand
Partner/Principal, Forensic & Integrity Services, EY |
David Falcone
Associate Vice President Global Compliance, Merz Aesthetics |
J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC
|
Nicole L. Felician, JD
Executive Director, Legal Regulatory, Digital Health, Patient Centricity, Cell Therapies, Astellas Pharma US |
Margaret K. Feltz, MA, JD
Vice President, Ethics and Compliance, Purdue Pharma LP |
Kellie Fidler, PMP
Senior Director, Compliance Risk Assessment, Monitoring and Operations, Bristol-Myers Squibb
|
Bethany Fox, JD
Vice President, Commercial Legal Affairs, Exelixis |
Sara Frank, JD
Principal, Choate, Hall & Stewart LLP |
Sarah A. Franklin, JD
Partner and Vice-chair, Life Sciences Litigation and Investigations Practice Group, Covington & Burling LLP
|
Cari A. Gallman, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol Myers Squibb |
Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda |
Gary F. Giampetruzzi, JD
Partner, Paul Hastings
|
Tara K. Giunta, JD
Partner, Paul Hastings |
Edward P. Glynn, MBA
Principal, EY |
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, USDOJ
|
Tom Gregory
Partner, Forensic & Integrity Services, EY |
Noor Haq, MBA, MS, CCEP
Executive Director, US Compliance, Amgen |
Beth Hardcastle, JD
Partner, Sidley Austin LLP
|
Judith Haron, JD
Assistant General Counsel, PhRMA; Former Acting Chief Counsel, HHS |
Todd Haugh, JD
Associate Professor of Business Law and Ethics, Kelley School of Business, Indiana University |
Saul B. Helman MD, MBA
President, Epsilon Life Sciences
|
Kevin Henley, JD
Vice President, US Chief Compliance Officer, Otsuka America Pharmaceutical, Inc |
Michael Hercz, JD
Senior Vice President & General Counsel, Sentynl |
Emily F. Hodge, JD
Partner, Choate, Hall & Stewart LLP
|
Denis Jacob
Managing Director, Risk & Regulatory, PwC |
Brenna E. Jenny, JD
Partner, Sidley |
Abe Kassis, MBA, PhD
Senior Director, Global Head of Compliance and Legal Operations, Bausch + Lomb
|
Jeffrey Kawalek, MBA
Deputy, Chief Compliance Officer, Jazz Pharmaceuticals |
Andrea Kocharyan, JD
Vice President, Head of Legal and Compliance, Zealand Pharma |
Daniel Koerner
Senior Director, Potomac River Partners
|
Kirt Kraeuter, MGA
Senior Director, Corporate Compliance, Moderna |
JJ Kuhn, JD
Vice President, Chief Counsel, Global Investigations, Medtronic |
Stephanie Kurteff, JD, HCCP
Head of Compliance, Healthcare Compliance Officer, Medicines360
|
Rebekah Latchis, JD
Senior Director, Americas Office of Ethics and Compliance, Medtronic |
Rachel Lei, JD
Vice President and General Counsel, Aldevron |
Kirsten Liston
Principal and Founder, Rethink Compliance
|
Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting US Attorney, Massachusetts, DOJ |
Seth H. Lundy, JD
Partner, FDA and Life Sciences, King & Spalding |
Kevin J. Ma, JD
US Head of Compliance & Managing Counsel, PharmaEssentia USA
|
Jason Macias, JD
Head of Risk Assessment, Monitoring, Transparency, Global Trade, and Medical Affairs Compliance, Viatris |
Jim Massey, MS
Chief Sustainability Officer, Zai Lab |
Chris C. Matteson
US Forensics Compliance Services Executive, Forensic & Integrity Services, EY
|
Kirsten Mayer, JD
Head of US Compliance, Argenx |
Dana S. McMahon, JD
Vice President, Global Chief Compliance Officer, Stryker |
Rore Middleton, JD
Vice President, Compliance and Ethics at Blueprint Medicines, Member of Chief
|
David Mortlock, JD
Managing Partner, Global Trade & Investment Group, Willkie Farr & Gallagher LLP |
Gregory S. Moss, JD
Chief Corporate Strategy and Legal Officer, Evommune |
Lucy Muzzy, JD
Vice President, Compliance, Pfizer
|
Gregory F. Noonan, JD
Partner, Hogan Lovells; Former AUSA, Massachusetts & Southern District of California |
Katherine Norris, MPA
Managing Director, Epsilon Life Sciences |
Kristen Oberg, JD
Senior Vice President, Legal & Compliance, Mycovia Pharmaceuticals
|
Daniel O’Connor
Senior Vice President, PharmaCertify |
John Patrick Oroho, JD
Executive Vice President, Chief Strategy Officer, Porzio Life Sciences; Principal, Porzio, Bromberg & Newman PC |
Chelsea Ott, JD
Director, Global Regulatory, MedPro Systems
|
Amy Pawloski, CCEP
President, Strategic Versatility |
Veleka R. Peeples-Dyer, JD
Chief Legal Officer and Chief Compliance Officer, Opentrons Labworks |
Danielle Pelot, JD
Partner, Choate, Hall & Stewart LLP
|
Joseph Philipose, JD
SVP, Chief Ethics & Compliance Officer, Emergent Biosolutions |
Zoe Philippides, JD
Senior Vice President, Chief Ethics, Compliance & Privacy Officer, Moderna |
Susan Pietras
Global Project Lead - Training, Communication and Policies, Sanofi
|
Lawrence P. Platkin, JD
Vice President and Head, U.S. Office of Compliance, Bayer US |
Cory Potomis, MS
Director, Ethics & Compliance Strategy & Operations, Novo Nordisk, Plainsboro, NJ |
Nikki Reeves, JD
Partner & Co-chair, Life Sciences and Healthcare Industry Group, King & Spalding
|
Jennifer A. Romanski, JD
Senior Vice President, Porzio Life Sciences, LLC; Principal, Porzio, Bromberg & Newman PC |
Howard Root, JD
Chairman, Reprise Biomedical; Former, CEO & Co-Founder, Vascular Solutions |
Jeff Rosenbaum, MBA
Partner & Co-Founder, Dovetail Consulting Group
|
David Ryan, JD
Vice President and Chief Compliance Officer, Epizyme |
Monica Schroeter, CPA, CISA
Senior Director, Compliance & Privacy , SK Life Science |
Michael L. Shaw, JD
Principal, Global Head of Risk & Compliance, ZS
|
Tara Shewchuk, JD, LLM
Chief Ethics & Compliance Officer, Medtronic |
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory |
Ed Sleeper, MS
Ethics & Compliance Officer (U.S. & Europe), HUTCHMED
|
Tim Slone, MS, HCCP
Vice President, Global Compliance, Novavax |
Damon Strickland
Associate Vice President, Ethics & Compliance Global Operational Capabilities, Eli Lilly |
Kaarthick Subramanian, MBA
Chief Compliance Officer, Atlas Systems
|
Jack Tanselle, MBA
Managing Director, Deloitte & Touche LLP |
Bryan Timer, MBA
Director, Global Compliance, Data Analytics and Transparency COE, Merck |
Kelly J. Tope, JD, MBA
Head of USBU Ethics & Compliance Monitoring and Reporting Operations, Takeda
|
Annalisa Torrente-Haney, MS
Associate Director, Contract to Pay Operations US Business Partner, AstraZeneca |
Manny Tzavlakis
Managing Partner, Helio Health Group; Chief Executive Officer, Helio Argos |
Beth P. Weinman, JD
Counsel, Ropes & Gray; Former Associate Chief Counsel, FDA
|
Caroline West, JD
Principal, Loganbrook Advisory LLC; Former SVP Global CCO, Olympus |
Amy Wilson, MBA, MSJ
Vice President and Chief Compliance Officer, Esperion Therapeutics
|
Ronald L. Wisor, Jr, JD
Partner, Hogan Lovells |
Olga Zinavenka, CPA, MBA
Senior Director, Compliance Investigations, Endo International
|
|
|
REGISTER BY 9/23 FOR EARLY BIRD RATE
|
Click Here for discounted registration.
|
|
AGENDA NOW AVAILABLE
|
Click Here for Agenda.
|
|
SPONSORED BY
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of compliance professionals including compliance officers and senior legal counsels from 100+ distinguished researched-based pharmaceutical manufacturers and biotech companies.
|
|
PRODUCED BY
|
|
|
PCF EXECUTIVE COMMITTEE
|
Joe Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics
(PCF Chair)
Christie Camelio
Chief Compliance and Risk Officer, EQRx
Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte
Joshua M. Marks, JD
Global Head of E&C Program and Governance, Takeda Pharmaceuticals
Margaret Sparks, JD
Head of Compliance, Vaccines & North America Ethics and Business Integrity, Sanofi
Donna White, CCEP
Vice President, Compliance, Chiesi
|
|
MEDICAL DEVICE EXECUTIVE STEERING COMMITTEE
|
Sujata Dayal, JD
Vice President & Global Chief Compliance Officer, Medline Industries, Inc.
Tara Shewchuk, JD
Chief Ethics & Compliance Officer, Medtronic
Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
|
GRANTORS
|
|
SILVER
|
|
|
BRONZE
|
|
|
EXHIBITORS:
|
|
|
MEDIA PARTNERS:
|
|
|
CONTINUING EDUCATION:
|
COMPLIANCE CERTIFICATION BOARD CONTINUING EDUCATION UNITS (CCB CEUs)
The Congress is pending approval for Compliance Certification Board (CCB)® Continuing Education Units.
CONTINUING LEGAL EDUCATION
The Congress is pending approval for Pennsylvania CLE Credits.
CERTIFICATE OF ATTENDANCE
Attendees can click here to request a Certificate of Attendance on which they can certify the number of hours they watched and can file with appropriate entities for credit.
|
|
TUITION SCHOLARSHIPS:
|
The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those who have lost their jobs as a result of the COVID-19 pandemic.
Click here for more information.
|
|
|
|
CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
|
|
For sponsorship and exhibit information contact Suzanne Tyler, Exhibit Manager, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
|
